Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

50.0%

-36.6% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT04729933Not ApplicableActive Not Recruiting

Implantation of a Permanent Interatrial Shunt to Reduce Left Atrial Filling Pressures Following MitraClip

Role: collaborator

NCT07696975Not ApplicableNot Yet Recruiting

RELIEVE-HFrEF TRIAL: REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure With Reduced EF

Role: lead

NCT03838445Not ApplicableActive Not Recruiting

Reducing Right Ventricular Failure in Pulmonary Arterial Hypertension (RELIEVE-PAH)

Role: lead

NCT03499236Not ApplicableActive Not Recruiting

Reducing Lung CongestIon Symptoms in Advanced Heart Failure

Role: lead

NCT02511912Not ApplicableWithdrawn

Heart Failure (HF) Interatrial Shunt Study 1

Role: lead

NCT01965015Not ApplicableCompleted

The V-Wave Shunt: FIM Safety and Feasibility Study

Role: lead

All 6 trials loaded